Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Antipsoriatic efficacy of topical formulations in psoriasis plaque test
2006-001186-42Phase 2Completed
- Sponsor
- Astion Pharma
- Start
- May 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised trial of ASF-1075 in psoriasis (6 arms), sponsored by Astion Pharma. Primary endpoint: Primary efficacy. Started May 2006; status: completed.
02
Drugs
ASF-1075
03
Conditions
psoriasis
Beyond the preview
Go deeper on 2006-001186-42.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-001186-42.